[Use of flow cytometry in diagnosis of urinary bladder cancer].
Urinary bladder cancer ranks 11th (10-15 cases per 100,000 annually) in the oncological morbidity registry. Morphological diagnosis is generally confirmed by cytological assay of urinary sediment or lavage liquid. Yet, the method is effective only with low-differentiated cell tumor. Flow cytometry was used at the Center's Clinic (2005-2006) to test urinary sediment from 32 patients diagnosed with bladder cancer. In addition, all patients were tested 3 times by the standard cytological procedure using a mix of azure and eosin (Pappenheim). The sensitivity of the latter method proved to be 31.3% as compared with 65.62% for flow cytometry.
Bozhenko
V K
VK
Kaprin
A D
AD
Kostin
A A
AA
Kulinich
T M
TM
Kudinova
E A
EA
Chazova
N L
NL
Mel'nikova
N V
NV
Nesterov
P V
PV
D000368:Aged; D000369:Aged, 80 and over; D003937:Diagnosis, Differential; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000473:pathology